DEO vs JAZZ · P/E 16, $55.86B cap vs P/E 1988, rev $2.28B
Diageo PLC ADR (DEO) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
DEO does not have a complete income-statement cache yet.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
DEO currently screens at market cap $55.86B and trailing P/E 15.6. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the DEO and JAZZ stock pages for the full models.
Not investment advice.